HEMOPHILIA

This early-stage study tested a new drug called MG1113 in 15 men with severe hemophilia A or B. The goal was to check if the drug is safe and how it works in the body. Participants received multiple doses under the skin. The study is complete, and results will help decide if larg…

This study tested a low-cost platelet-rich plasma (PRP) injection to help with joint pain and swelling caused by bleeding disorders like hemophilia. Fourteen adults with joint problems in their ankle, knee, or elbow received the injection. The goal was to see if the low-cost meth…

This study looked at whether manual therapy (hands-on treatment) and structured exercises could improve balance and walking ability in adults with hemophilia. Thirty-five adults with moderate or severe hemophilia took part. Half received 12 physiotherapy sessions over 6 weeks, wh…

This study tested a new physiotherapy technique called blood flow restriction for people with hemophilia who have ankle joint damage. 31 patients participated across four regions in Spain. The goal was to see if this approach could safely improve muscle strength, reduce pain, and…

This study looked at whether a special low-intensity exercise program, using bands to gently restrict blood flow, is safe and helpful for adults with moderate or severe hemophilia. Twenty participants did arm and leg exercises twice a week for 8 weeks. Researchers measured change…

This study looked at how well children with hemophilia (a bleeding disorder) breathe, exercise, and stay active compared to healthy children. Researchers tested 34 kids aged 8-18 using lung function tests, bike exercise tests, and activity questionnaires. The goal was to see if h…

This study examined how COVID-19 lockdowns impacted over 1,300 people with chronic conditions like heart disease, multiple sclerosis, and hemophilia. Researchers looked at changes in medication use, lifestyle habits, and stress levels. The goal was to understand the health risks …

This study looked at how different preventive treatments for moderate or severe hemophilia A affect the daily lives of boys aged 7 to 18 and their families. Researchers compared an intravenous factor replacement product with a subcutaneous non-factor product by having participant…

This study looked at why people with hemophilia and damaged knee or ankle joints often feel more pain than expected. Researchers measured central sensitization—a condition where the nervous system becomes overly sensitive to pain—in 146 adults. They also checked for fear of movem…